Literature DB >> 10559704

Effects of serotonin-selective and classical antidepressants on the auditory P300 cognitive potential.

X L d'Ardhuy1, P H Boeijinga, B Renault, R Luthringer, G Rinaudo, L Soufflet, M Toussaint, J Macher.   

Abstract

The cognitive potential, P300, is a phenomenon frequently studied in relation to template matching of the brain. To understand the neurochemical mechanisms of its generation, we compared the effects of three antidepressants, fluoxetine, tianeptine and clomipramine after single and repeated application as well as after 1 week of withdrawal on the P300 and N200 waves in an auditory 'odd-ball' paradigm in three parallel groups of 10 healthy volunteers. Following single administration, both fluoxetine and clomipramine reduced (-39 +/- 14%, p < 0.01) the peak amplitude of P300 at the Pz electrode. For fluoxetine and tianeptine, reduced amplitudes of 19 +/- 7% and 24 +/- 11%, respectively, were found following 8 days of treatment, 2 h after administration. However, for clomipramine no additional diminution was found on day 8 with respect to day 1. Topographic distributions tended to be significantly modified at the frontal scalp area 1 h after the tianeptine administration on day 8, whereas the postdosing changes induced by fluoxetine were localised in the midline and right centrotemporal scalp regions. Only minor reductions in peak latencies have been observed. It can be concluded that serotonin selective drugs have a slower onset of P300 amplitude decrease than clomipramine, which has additional effects on monoaminergic and on cholinergic systems. These results suggest that serotonin has a regulatory function in the neurotransmission of cerebral structures which are involved in the evaluation of stimulus relevance.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10559704     DOI: 10.1159/000026621

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  10 in total

Review 1.  Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy subjects.

Authors:  G J H Dumont; S J de Visser; A F Cohen; J M A van Gerven
Journal:  Br J Clin Pharmacol       Date:  2005-05       Impact factor: 4.335

2.  Increased neural sensitivity to self-relevant stimuli in major depressive disorder.

Authors:  Erik M Benau; Kaylin E Hill; Ruth Ann Atchley; Aminda J O'Hare; Linzi J Gibson; Greg Hajcak; Stephen S Ilardi; Dan Foti
Journal:  Psychophysiology       Date:  2019-02-22       Impact factor: 4.016

3.  Association of lifetime major depressive disorder with enhanced attentional sensitivity measured with P3 response in young adult twins.

Authors:  Sini M Koskinen; Jyrki Ahveninen; Teija Kujala; Jaakko Kaprio; Brian F O'Donnell; Daria Osipova; Richard J Viken; Risto Näätänen; Richard J Rose
Journal:  Biol Psychol       Date:  2022-05-05       Impact factor: 3.111

4.  The influence of psychological state and motivation on brain-computer interface performance in patients with amyotrophic lateral sclerosis - a longitudinal study.

Authors:  Femke Nijboer; Niels Birbaumer; Andrea Kübler
Journal:  Front Neurosci       Date:  2010-07-21       Impact factor: 4.677

5.  Changes in neural circuitry of language before and after treatment of major depression.

Authors:  Yalçin Abdullaev; Barbara L Kennedy; Allan Tasman
Journal:  Hum Brain Mapp       Date:  2002-11       Impact factor: 5.038

6.  Long-term event-related potential changes following organophosphorus insecticide poisoning.

Authors:  T Dassanayake; V Weerasinghe; U Dangahadeniya; K Kularatne; A Dawson; L Karalliedde; N Senanayake
Journal:  Clin Neurophysiol       Date:  2007-11-26       Impact factor: 3.708

7.  Objective markers of drug effects on brain function from recordings of scalp potential in healthy volunteers.

Authors:  Peter H Boeijinga
Journal:  Dialogues Clin Neurosci       Date:  2002-12       Impact factor: 5.986

8.  Magnetoencephalography of cognitive responses A sensitive method for the detection of age-related changes.

Authors:  P H Boeijinga
Journal:  Dialogues Clin Neurosci       Date:  1999-12       Impact factor: 5.986

9.  Human models as tools in the development of psychotropic drugs.

Authors:  Christian Gilles; Thérèse Schunck; Gilles Erb; Izzie Jacques Namer; Yann Hodé; Jean-François Nedelec; Peter Boeijinga; Remy Luthringer; Jean-Paul Mâcher
Journal:  Dialogues Clin Neurosci       Date:  2002-12       Impact factor: 5.986

10.  Dysfunctional information processing during an auditory event-related potential task in individuals with Internet gaming disorder.

Authors:  M Park; J-S Choi; S M Park; J-Y Lee; H Y Jung; B K Sohn; S N Kim; D J Kim; J S Kwon
Journal:  Transl Psychiatry       Date:  2016-01-26       Impact factor: 6.222

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.